Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid Maintenance After Treanda and Rituxan in Relapsed/Refractory CLL/SLL
NCT00974233Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2009
- Primary completion
- Jul 2013
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by University of Wisconsin–Madison. Started Oct 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00974233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974233.